Results Press Release
Panacea Biotec Ltd has informed BSE regarding a Press Release dated October 21, 2011, titled "Panacea Biotec reports financial reports for the Quarter & Half year ended September 30, 2011".21-10-2011
21-10-2011
Financial Results for Sep 30, 2011
Panacea Biotec Ltd has informed BSE about the Financial Results for the period ended September 30, 2011.21-10-2011
Credit Ratings
Panacea Biotec Ltd has informed BSE that Credit Analysis & Research Ltd (CARE) has retained the existing ratings of the Company with respect to the various Bank Facilities availed by the Company.1. Facilities/Instruments: Long-term Bank Facilities- Amount (Rs. Crore): 1379.42- Rating: 'CARE A-' (Single A Minus)- Remarks: Placed under 'Credit Watch'...19-10-2011
Outcome of AGM
Panacea Biotec Ltd has informed BSE that the members at the 27th Annual General Meeting (AGM) of the Company held on September 24, 2011, inter alia, have accorded to the following:1. Adoption of the Audited Balance Sheet and Profit and Loss Account for the year ended on March 31, 2011, together with Auditors and Directors Report thereon....30-09-2011
AGM on Sept 24, 2011
Panacea Biotec Ltd has informed BSE that the 27th Annual General Meeting (AGM) of the members of the Company will be held on September 24, 2011 at 11.00 A.M. at the Registered Office of the company at Ambalal-Chandigarh Highway, Lalru - 140501, Punjab to transact the following business:1. To receive, consider and adopt the Audited Balance Sheet as at March 31, 2011 and the Profit & Loss Account for the year ended on that date and the reports of Directors and Auditors thereon....05-09-2011
WHO delist Company's DTP-based combination and monovalent hepatitis B vaccines from its list of pre-qualified vaccines
Panacea Biotec Ltd has informed BSE regarding "WHO delist Company's DTP-based combination and monovalent hepatitis B vaccines from its list of pre-qualified vaccines""Following a routine site audit conducted by a WHO team, of the manufacturing facility of PanEra Biotec Pvt. Ltd. (our associate Company) at Lalru, and the conclusions of an ad-hoc committee convened by WHO, the Company's following diphtheria-pertussis-tetanus based combination...17-08-2011
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Panacea Biotec Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:10-08-2011
Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Panacea Biotec Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:10-08-2011
Limited Review for the quarter ended June 30, 2011
Panacea Biotec Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2011.06-08-2011
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Dr. Rajesh Jain has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:03-08-2011